Taking a new path in pain management (Amended)
iX Biopharma wants to be the first in the world to get ketamine registered in the US as an alternative to opioid - the only pain management drug administered by doctors.
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
WITH one day to go before it trades on the Catalist, late-stage specialty pharmaceutical firm iX Biopharma has already caught the eyes of interested parties.
This might have something to do with the firm's niche, which lies in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium
